CPT® Code 0401T

Deleted

1. Indications

The multi-spectral digital skin lesion analysis using CPT® Code 0401T is indicated for the evaluation of clinically atypical cutaneous pigmented lesions. This procedure is particularly useful in the following scenarios:

• Detection of Melanomas This procedure assists in the early identification of melanomas, which are aggressive forms of skin cancer that can develop from atypical pigmented lesions.
• High-Risk Melanocytic Atypia The analysis helps in identifying lesions that exhibit high-risk characteristics for melanocytic atypia, which may indicate a potential for malignancy.
• Monitoring Suspicious Pigmented Lesions The procedure is beneficial for monitoring changes in clinically ambiguous skin lesions over time, allowing for timely intervention if necessary.

2. Procedure

The multi-spectral digital skin lesion analysis procedure involves several key steps to ensure accurate evaluation of the lesions. The following outlines the procedural steps:

• Step 1: Preparation The patient is positioned comfortably, and the skin lesions to be analyzed are identified. The area may be cleaned to ensure optimal scanning conditions.
• Step 2: Scanning A handheld scanner is utilized to emit wavelengths of light that penetrate the skin lesions. This scanner is designed to cover multiple lesions, specifically six or more, as indicated by CPT® Code 0401T.
• Step 3: Data Collection As the scanner emits light, it collects data regarding the cellular morphology of the lesions. This data is crucial for the subsequent analysis.
• Step 4: Algorithmic Analysis The collected data is processed by specialized computer software, which analyzes the information and generates an algorithmic score for each lesion based on the degree of morphological disorganization.
• Step 5: Interpretation of Results The algorithmic scores are reviewed, with scores less than 0 indicating low suspicion and scores of 0 or more indicating a high degree of suspicion for malignancy. This information guides further clinical decisions.

3. Post-Procedure

After the multi-spectral digital skin lesion analysis is completed, the healthcare provider will discuss the results with the patient. For lesions that receive a positive algorithmic score, further histological examination, such as a biopsy, is recommended to confirm the diagnosis and determine the appropriate course of action. In contrast, lesions that are scored negatively can be monitored over time for any changes, with follow-up appointments scheduled as necessary. The provider may also advise on any additional skin care or monitoring strategies to ensure the patient's ongoing skin health.